Resolve Biosciences
Marko Labus serves as the Chief Financial Officer and Executive Vice President at Resolve BioSciences since September 2023, overseeing global finance, IT, and administration with a focus on fundraising and equity initiatives. Previously, Marko held the position of Vice President Finance and Controlling at Syntegon from September 2020 to June 2023, responsible for the global finance and controlling functions. Marko also served as Finance Controller Europe at IAC Group between December 2015 and June 2020, and held various director roles within the organization. Earlier in Marko's career, significant experience was gained at KPMG Germany from November 2001 to December 2015, managing international audit clients and resolving complex IFRS accounting issues. Marko Labus earned a Diplom Kaufmann degree in Betriebswirtschaftslehre from the University of Münster from October 1996 to October 2001.
This person is not in any teams
Resolve Biosciences
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.